세계의 다운스트림 프로세싱 시장 보고서(2025년)
Downstream Processing Global Market Report 2025
상품코드 : 1824274
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 다운스트림 프로세싱 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 13.4%로 확대되어 586억 8,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 바이오의약품 수요 증가, 지속가능한 녹색 가공에 대한 주목, 공동연구와 파트너십, 지속적인 바이오가공 채용, 개별화 의약품 수요 증가 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 디지털화와 산업 40의 통합, 기술 진보, 단일 사용 시스템, 바이오 의약품 산업의 성장, 연속 처리 등이 포함됩니다.

향후 5년간의 성장률 13.4%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 스웨덴과 독일에서 수입되는 크로마토그래피 수지 및 여과 시스템의 가격을 상승시켜 중요한 치료의 제조 비용을 증가시켜 미국 생물 제제의 생산을 혼란시킬 수 있습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 가해질 수 있습니다.

예상되는 헬스케어 지출 증가는 다운스트림 프로세싱 시장의 향후 확대의 원동력이 될 것으로 예측됩니다. 헬스케어 지출에는 보건 서비스, 가족 계획 활동, 영양 이니셔티브, 보건 관련 목적에 특별히 할당된 긴급 지원과 관련된 모든 지출이 포함됩니다. 이러한 지출 증가는 박테리아 또는 동물 세포와 같은 천연 공급원으로부터 약물 물질(DS)을 추출한 후 약물 물질을 정제하기 위한 매우 중요한 구성요소인 다운스트림 프로세싱의 판매를 강화할 것으로 예측됩니다. 미국 메디케어 & 메디케이드 서비스센터에 의한 2021-2030년 국민의료비(NHE) 보고서에 따르면 2022년 3월 현재 국민의료비의 연간 증가율은 2021-2030년 사이에 평균 5.1%, 2030년에는 약 6조 8,000억 달러에 달할 것으로 예측됩니다. 같은 기간 동안 메디케어 지출은 연률 7.2%, 메디케이드 지출은 연률 5.6%로 증가할 것으로 예측됩니다. 이와 같이, 헬스케어 지출 증가는 다운스트림 프로세싱 시장의 성장에 크게 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Downstream processing involves the retrieval and purification of a drug substance (DS) derived from natural sources such as animal or bacterial cells. It delineates the sequence of steps essential to generate a pure and uniform protein product from biological components such as cells, tissue culture fluid, or plant tissues.

Key products utilized in downstream processing encompass centrifuges, dryers, chromatography systems, filters, evaporators, and others. Various techniques are applied, including purification methods, solid-liquid separation, and clarification or concentration. Centrifuges are devices that leverage centrifugal force to separate materials based on different densities, eliminate moisture, or replicate the effects of gravity. They find applications in diverse areas such as monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The downstream processing market research report is one of a series of new reports from The Business Research Company that provides downstream processing market statistics, including downstream processing industry global market size, regional shares, competitors with a downstream processing market share, detailed downstream processing market segments, market trends and opportunities, and any further data you may need to thrive in the downstream processing industry. This downstream processing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The downstream processing market size has grown rapidly in recent years. It will grow from $31.26 billion in 2024 to $35.45 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to increasing biopharmaceutical investments, stringent regulatory standards, globalization of biopharmaceutical production, rising incidence of chronic diseases.

The downstream processing market size is expected to see rapid growth in the next few years. It will grow to $58.68 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing demand for biopharmaceuticals, focus on sustainable and green processing, collaborations and partnerships, continuous bioprocessing adoption, increasing demand for personalized medicines. Major trends in the forecast period include digitalization and industry 40 integration, technological advancements, single-use systems, biopharmaceutical industry growth, continuous processing.

The forecast of 13.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could disrupt U.S. biologic drug production by inflating prices of chromatography resins and filtration systems imported from Sweden and Germany, resulting in higher manufacturing costs for critical therapies. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated increase in healthcare expenditure is poised to be a driving force for the future expansion of the downstream processing market. Healthcare expenditure encompasses all spending related to health services, family planning activities, nutrition initiatives, and emergency aid specifically allocated for health-related purposes. This heightened expenditure is expected to bolster the sales of downstream processing, a pivotal component in extracting drug substances (DS) from natural sources such as bacterial or animal cells and subsequently purifying the drug substance. According to the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services in the United States, as of March 2022, the annual increase in national health spending is projected to average 5.1% between 2021 and 2030, reaching an approximate total of $6.8 trillion by 2030. Over the same period, Medicare expenditures are expected to grow at a 7.2% annual rate, while Medicaid spending is projected to increase at a 5.6% annual rate. Thus, the escalating healthcare expenditure significantly contributes to the downstream processing market's growth.

The anticipated growth in the biopharmaceutical sector is expected to drive the future expansion of the downstream processing market. The biopharmaceutical sector, a segment of the pharmaceutical industry specializing in the development, manufacturing, and commercialization of drugs and therapies derived from biological sources, is set to increase the demand for downstream processing (DSP). DSP is a crucial stage in the biopharmaceutical manufacturing process, responsible for isolating, purifying, and concentrating the desired drug substance from the complex mixture obtained after upstream processing. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, reported that the total pharmaceutical production in Europe amounted to $384,200 million (€340,000 million) in 2022, reflecting an increase of approximately 4.95% from $366,267 million (€323,950 million) in 2021. Therefore, the rising demand in the biopharmaceutical sector is a key driver for the downstream processing market's growth.

A prominent trend gaining traction is the emphasis on product innovations. Leading companies in the market are dedicated to developing new technological solutions as part of their strategy to solidify their market presence. For example, in September 2022, Tosoh Bioscience LLC, a global chemical and specialty materials company based in the United States, introduced the Octave BIO Multi-Column Chromatography (MCC) system. This innovative system serves as a comprehensive solution for downstream process intensification, specifically designed for advanced biomolecule purification processes. Its modular design allows flexibility to accommodate diverse requirements, offering advantages such as resin and buffer cost savings.

A key focus of major companies in the downstream processing market is on pioneering solutions, including the implementation of flow cells to drive revenue growth. A flow cell is a specialized container designed for the continuous flow of liquid samples. For instance, in October 2023, SCHOTT AG, a Germany-based technology group specializing in specialty glass and glass-ceramics, launched ViewCell. This new component aims to facilitate safe and continuous process control, optimizing downstream operations in the biopharmaceutical industry. The flexibility provided by the viewcell flow cell is expected to enhance the efficiency of downstream processes in the biopharmaceutical industry.

In January 2023, Astea Bio separations, a UK-based provider of bioseparation and purification technologies, completed the acquisition of Delta Precision Ltd. for an undisclosed amount. This acquisition positions Astea Bio separations to strengthen its existing portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns by incorporating a wide range of high-performance chromatography columns for biomanufacturing. Delta Precision Ltd., a UK-based manufacturer of advanced chromatography columns, produces products for various applications, including protein purification, vaccine production, and drug development.

Major companies operating in the downstream processing market include Sartorius AG, General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Repligen Corporation, Lonza Group Ltd., Eppendorf AG, Corning Corporation, Ashai Kasei Corporation, Finesse Solutions Inc., MilliporeSigma, Pall Corporation, Bio-Rad Laboratories, Charles River Laboratories International Inc., Waters Corporation, Becton Dickinson and Company (BD), Entegris Inc., Novasep, Avantor Sciences, Tecan Group, Agilent Technologies, Boehringer Ingelheim International GmbH, Ahlstrom-Munksjo Oyj, Grifols S.A., GenScript Biotech Corporation

North America was the largest region in the downstream processing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global downstream processing market report during the forecast period. The regions covered in the downstream processing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the downstream processing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The downstream processing market consists of revenues earned by entities by providing downstream processing services such as cell separation, filtration, product recovery, extraction of products, and more. The market value includes the value of related goods sold by the service provider or included within the service offering. The Downstream processing market also includes sales of small-scale fermenters, pilot-scale fermenters, centrifuges, and membrane filtration systems which are used in providing downstream processing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Downstream Processing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on downstream processing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for downstream processing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The downstream processing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Downstream Processing Market Characteristics

3. Downstream Processing Market Trends And Strategies

4. Downstream Processing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Downstream Processing Growth Analysis And Strategic Analysis Framework

6. Downstream Processing Market Segmentation

7. Downstream Processing Market Regional And Country Analysis

8. Asia-Pacific Downstream Processing Market

9. China Downstream Processing Market

10. India Downstream Processing Market

11. Japan Downstream Processing Market

12. Australia Downstream Processing Market

13. Indonesia Downstream Processing Market

14. South Korea Downstream Processing Market

15. Western Europe Downstream Processing Market

16. UK Downstream Processing Market

17. Germany Downstream Processing Market

18. France Downstream Processing Market

19. Italy Downstream Processing Market

20. Spain Downstream Processing Market

21. Eastern Europe Downstream Processing Market

22. Russia Downstream Processing Market

23. North America Downstream Processing Market

24. USA Downstream Processing Market

25. Canada Downstream Processing Market

26. South America Downstream Processing Market

27. Brazil Downstream Processing Market

28. Middle East Downstream Processing Market

29. Africa Downstream Processing Market

30. Downstream Processing Market Competitive Landscape And Company Profiles

31. Downstream Processing Market Other Major And Innovative Companies

32. Global Downstream Processing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Downstream Processing Market

34. Recent Developments In The Downstream Processing Market

35. Downstream Processing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기